Institutional investors hold a majority ownership of CELG through the 82.01% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2017, these large investors purchased a net $11.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTHERN TRUST GLOBAL INVESTMENT... Bought 102.4 Thousand shares of Celgene
LPL FINANCIAL LLC Bought 92.1 Thousand shares of Celgene
CANDRIAM BELGIUM SA Bought 65.6 Thousand shares of Celgene